Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by F. Micciche'
Chemotherapy Plus Concomitant Low-Dose Fractionated Radiotherapy as Second-Line Treatment for Recurrent or Progressive Glioblastoma After Temozolomide-Based Chemoradiation: A Pilot Study.
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Related publications
Apatinib Plus Temozolomide for Recurrent Glioblastoma: An Uncontrolled, Open-Label Study
OncoTargets and Therapy
Oncology
Pharmacology
Weekly Paclitaxel as Second-Line Chemotherapy for Advanced or Recurrent Gastric Cancer
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Single Dose Bevacizumab as Treatment for Symptomatic, Corticosteroid-Refractory Pseudoprogression After Chemoradiation Therapy for Newly Diagnosed Glioblastoma: A Case Report
Integrative Cancer Science and Therapeutics
Survival Benefit of Glioblastoma Patients After FDA Approval of Temozolomide Concomitant With Radiation and Bevacizumab: A Population-Based Study
Oncotarget
Oncology
Hyper-Fractionated Radiotherapy for Soft Tissue Sarcoma: Results of the Second Study of Hyper-Fractionated Radiotherapy
Sarcoma
Nuclear Medicine
Radiology
Imaging
Oncology
Anti-Pd-1 Therapy Plus Chemotherapy and/or Bevacizumab as Second Line or Later Treatment for Patients With Advanced Non-Small Cell Lung Cancer
Journal of Cancer
Oncology
Necrotizing Fasciitis: Low-Dose Radiotherapy as a Potential Adjunct Treatment
Dose-Response
Chemical Health
Mutagenesis
Public Health
Environmental
Safety
Toxicology
Health
Occupational Health
Predictors of Survival After Second Surgery for Recurrent Glioblastoma Tumours
Canadian Journal of Neurological Sciences
Medicine
Neurology
Elective Lymph Node Irradiation Late Course Accelerated Hyper-Fractionated Radiotherapy Plus Concurrent Cisplatin-Based Chemotherapy for Esophageal Squamous Cell Carcinoma: A Phase II Study
Radiation Oncology
Nuclear Medicine
Radiology
Imaging
Oncology
